Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States

By sjmartinez • February 21, 2025

Pak K, Sachar R, Saab S. Projected Mitigation of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B in the Gray Zone and the Immune-Tolerant Phase in the United States. Dig Dis Sci. 2025 Feb 20. doi: 10.1007/s10620-025-08909-z. Epub ahead of print. PMID: 39979574.

Tags: Digestive Diseases, Gray zone, HCC, hepatitis B, Immune-tolerant, Publications

Randomized Controlled Trial of a Natural Whole Food Diet versus Habitual Diet for Crohn’s Disease: Is Diet Quality the Key?

Limketkai BN, Yang J, Chau L, Noorian S, Li Z. Randomized Controlled Trial of a Natural Whole Food Diet versus Habitual Diet for Crohn's Disease:[...]

A novel application of LC-MS/MS accurately quantifies the labile redox pools of cellular coenzymes Q9 and Q10

Jain A, Li VW, Salem J, Reddy ST, Palaskas NJ, Meriwether D. A novel application of LC-MS/MS accurately quantifies the labile redox pools of cellular[...]

Improved Survival in Malnourished COVID-19 Inpatients with Oral Nutrition Supplementation

Vong T, Yanek LR, Matarese LE, Limketkai BN, Mullin GE. Improved Survival in Malnourished COVID-19 Inpatients with Oral Nutrition Supplementation. Nutrients. 2025 Jul 23;17(15):2401. doi:[...]